Skip to main content
CME
NASDAQ Crypto Assets

CME Group Posts Record First Half, Q2 Revenue Hits $1.7B with Adjusted EPS of $2.99

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$239.87
Mkt Cap
$86.017B
52W Low
$218.31
52W High
$329.16
52W Position info
9.9% above low
Off High info
27% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

CME is trading near its 52-week low of $218.31 (9.9% above the low).

Summary

CME Group posted Q2 2026 revenue of $1.7 billion and adjusted diluted EPS of $2.99, capping a record first half. Record market data revenue and strong volumes highlight momentum, while $1.16 billion in capital returns signal confidence.


Key Events · Earnings and Guidance · CME

  • Record H1 2026 Performance

    The strongest first half in CME Group's history was driven by Q2 revenue of $1.7 billion, operating income of $1.1 billion, and net income of $1.0 billion. Adjusted diluted EPS rose to $2.99 from $2.96 in Q2 2025.

  • Record Market Data Revenue

    Reflecting robust demand for its data services, market data revenue surged 20% to a record $238 million in Q2.

  • Strong Trading Volumes

    Q2 average daily volume reached 29.8 million contracts, the third-highest quarterly ADV, fueled by interest rate and equity index products.

  • Capital Returns to Shareholders

    During Q2, the company paid $468 million in dividends and repurchased $695 million in shares, returning a total of $1.16 billion to shareholders.


Analysis · CME · Crypto Assets

CME Group delivered its strongest first half ever, with Q2 revenue of $1.7 billion and adjusted diluted EPS of $2.99, edging past the prior-year quarter's $2.96. Broad-based strength is underscored by record market data revenue of $238 million, up 20%, and the third-highest quarterly ADV of 29.8 million contracts. The company returned $1.16 billion to shareholders via dividends and buybacks, while holding $2.3 billion in cash against $3.4 billion in debt. These results land against a backdrop of aggressive product innovation and a high-stakes legal battle with the CFTC over perpetual futures, reinforcing CME's competitive positioning.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 30.5% of the 1996 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CME was trading at $239.87 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $86B. The 52-week trading range was $218.31 to $329.16. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CME - Latest Insights

CME
Sep 10, 2026, 11:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $275.20
Real-time Price: $274.07 info
Change: -$1.13 (-0.41%) info
Market Cap: $98.55B info
CME
Sep 09, 2026, 12:17 PM EDT
Source: The Block
Importance Score:
7
Price at Filing: $275.22
Real-time Price: $274.07 info
Change: -$1.15 (-0.42%) info
Market Cap: $98.55B info
CME
Sep 02, 2026, 11:39 PM EDT
Source: The Block
Importance Score:
7
Price at Filing: $278.15
Real-time Price: $274.07 info
Change: -$4.08 (-1%) info
Market Cap: $98.55B info
CME
Aug 12, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $259.00
Real-time Price: $274.07 info
Change: +$15.07 (+6%) info
Market Cap: $98.55B info
CME
Jul 22, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $240.00
Real-time Price: $274.07 info
Change: +$34.07 (+14%) info
Market Cap: $98.55B info